检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:刘亚巍[1,2] 刘晓[3] 林奕伟[4] 陈斌[4] 王刘江
机构地区:[1]解放军总参谋部警卫局卫生保健处,北京100017 [2]解放军医学院 [3]卫生部北京医院 [4]浙江大学医学院附属第一医院
出 处:《中国临床保健杂志》2013年第4期385-387,I0002,共4页Chinese Journal of Clinical Healthcare
基 金:军队保健专项科研课题项目(12BJZ25)
摘 要:目的探讨游离前列腺特异性抗原(PSA)百分比(f/tPSA)和PSA密度(PSAD)在PSA灰区(PSA介于4~10 ng/ml)患者中前列腺癌诊断的价值。方法回顾性分析258例于PSA灰区行前列腺穿刺活检患者的临床资料,按病理结果分为前列腺癌组(PCa组)和前列腺增生组(PBH组),比较两组f/tPSA和PSAD的差异;通过受试者工作特征(ROC)曲线分析法,评价f/tPSA和PSAD在预测前列腺癌中的价值。结果 258例中,病理确诊为前列腺癌70例,占27.13%。两组的f/tPSA和PSAD差异有统计学意义[PCa组vsBPH组:0.11±0.06 vs 0.16±0.07,(0.27±0.11)ng.ml-1.cm-3vs(0.20±0.09)ng.ml-1.cm-3,P<0.01]。ROC分析提示f/tPSA和PSAD的曲线下面积(AUC)分别为0.684和0.708,优于tPSA的AUC 0.566。结论 f/tPSA和PSAD是PSA灰区前列腺癌诊断理想的辅助参数。Objective To evaluate the value of free serum prostate-specific antigen(f/tPSA) percent and prostate-specific antigen density(PSAD) in detecting prostate cancer in men with 'gray zone' PSA.Methods We retrospectively assessed the clinical data of 258 patients with total PSA levels of 4-10ng / ml who underwent prostate biopsy.f / tPSA and PSAD was compared within two separate groups(PCa group and BPH group) according to biopsy re-sults.The diagnostic value of f / tPSA and PSAD for prostate cancer was investigated with receiver operator characteristic(ROC) curve analysis.Results Prostate biopsy specimens were positive for prostate cancer in the case of 70(27.13%) patients.The f/tPSA and PSAD were significantly different in the two groups(0.11 ± 0.06 vs 0.16 ± 0.07,0.27 ± 0.11 ng.ml-1.cm-3 vs 0.20 ± 0.09 ng.ml-1.cm-3,P 0.01).Area under the receiver operating characteristic(ROC) curves(AUC) for f / tPSA,PSAD were 0.684 and 0.708 respectively,which were significantly better than tPSA.Conclusion In patients with 'gray zone' PSA,f / tPSA and PSAD are ideal predictors,which should be utilized as further evaluation.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.7